Hepatotoxicity due to treatment with papaverine. Report of four cases.
D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001663:Bilirubin / Q000097:blood; D001706:Biopsy; D001831:Body Temperature; D056486:Chemical and Drug Induced Liver Injury; D004796:Clinical Enzyme Tests; D004342:Drug Hypersensitivity / Q000209:etiology; D004804:Eosinophils; D005260:Female; D006801:Humans; D007565:Jaundice / Q000139:chemically induced; D008099:Liver / Q000187:drug effects*; D008875:Middle Aged; D010208:Papaverine / Q000009:adverse effects*
D010208:Papaverine; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D000469:Alkaline Phosphatase; D001663:Bilirubin